Ocular Therapeutix, Inc. (OCUL)

NGM – Real Time Price. Currency in USD

10.28

+0.52 (5.32%)

Market open: Aug 12, 2026, 1:35 PM EDT

9.80

+0.04 (0.41%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

52M

64M

58M

51M

Cost of goods sold

-7M

-6M

-5M

Gross Profit

45M

58M

53M

47M

Operating expenses (excl. COGS)

-315M

-230M

-136M

-126M

Operating Income

-270M

-172M

-82M

-79M

Non-operating income, total

-22M

Pretax income

-266M

-194M

-81M

-71M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-266M

-194M

-81M

-71M

Discontinued operations

Net income

-266M

-194M

-81M

-71M

Dilution adjustment

-6M

Preferred dividends

Ocular Therapeutix, Inc. (OCUL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ocular Therapeutix, Inc. (OCUL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Ocular Therapeutix, Inc. (OCUL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ocular Therapeutix, Inc. (OCUL)

Income Statement (Annual)

Income Statement (Annual)